Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study by Glatt, S, Taylor, P, McInnes, I, Schett, G, Landewe, R, Baeten, D, Ionescu, L, Strimenopoulou, F, Watling, M, Shaw, S